Break it Down: Entropy’s IV psilocin delivers promising early BED trial results

In this episode, host Tylah Tully looks at Entropy Neurodynamics (ASX:ENP) who has received encouraging first results from a ...
Stockhead on MSN

Entropy’s psilocybin therapy shows rapid and sustained reduction of binge eating in 100pc of patients

Entropy Neurodynamics has received positive Phase 2a results for its psilocybin-based therapy in patients with Binge Eating Disorder. ... Read More The post Entropy’s psilocybin therapy shows rapid ...